Olympus announces the release of Acecide®-C, a new, peracetic acid-based high-level disinfectant and sterilant. Designed exclusively for use in the Olympus Endoscope Reprocessor, the OER-Pro, Acecide-C provides high-level disinfection in just seven minutes, making it the fastest-acting, room-temperature peracetic acid solution on the market.
Co-developed by Olympus and Saraya Co., Ltd. (manufactured by Best Sanitizers, Inc.), Acecide-C High-Level Disinfectant and Sterilant is an aldehyde-free, liquid chemical germicide designed for exclusive use with the OER-Pro. It has been tested and approved by Olympus for material compatibility with the OER-Pro and Olympus flexible endoscopes. With a 20°C (68°F) use temperature, Acecide-C protects equipment using non-heated chemistry while saving on energy costs and reducing the overall OER-Pro cycle time to just 26 minutes.
Further time-saving convenience is provided by Acecide-Cs unique, easy-to-handle cassette bottles, which deliver quicker and easier loading while minimizing staff exposure to the disinfectant thus increasing safety for the operator. In addition, time-saving test strips can check the solutions efficacy in just 13 seconds. Acecide-C, once loaded into the OER-Pro, can be used up to five days or when the minimum recommended concentration of 2000 ppm has been reached, whichever comes first.
Superior infection control solutions are of the utmost importance in the healthcare industry. The introduction of Acecide-C provides our OER-Pro customers with another fast and effective option to meet their reprocessing needs while protecting their valuable equipment, says Rick Harbuck, group vice president of the Endoscopy Division for Olympus America. We are pleased to collaborate with Saraya Co., Ltd., a recognized leader in the sanitation and healthcare industry, to enhance solutions for our customers, ultimately leading to better patient care.
The combination of Acecide-C with the Olympus OER-Pro gives a nearly perfect combination of ease of use, maximum microbiological efficacy, processing efficiency, instrument compatibility, and user and patient safety, says Duncan Badertscher, the director of R&D at Best Sanitizers, Inc.